Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Endogenous Gag-based capsids and uses thereof

Endogenous Gag-based capsids and uses thereof

US Patent 11447527 · Granted Sep 20, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tubulin inhibitors2025
Endogenous Gag-based capsids and uses thereof2022
Endogenous Gag-based capsids and uses thereof2022
Endogenous Gag-based capsids and uses thereof2022
Endogenous Gag-based capsids and uses thereof2022
Endogenous Gag-based capsids and uses thereof2022
Endogenous Gag-based capsids and uses thereof2022
Vaccine compositions comprising endogenous Gag polypeptides2021
Vaccine compositions comprising endogenous Gag polypeptides2021
Tubulin inhibitors2021
Titanium (IV) compounds and methods of forming heterocyclic compounds using same2018
Pretargeted activatable cell penetrating peptide with intracellularly releasable2018